Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;26(11):907-919.
doi: 10.1111/nep.13939. Epub 2021 Jul 28.

Reducing non-melanoma skin cancer risk in renal transplant recipients

Zaw Thet  1   2 , Alfred K Lam  1   3   4 , Dwarakanathan Ranganathan  1   5 , Soe Yu Aung  3   6 , Thin Han  2   3 , Tien K Khoo  1   7
Affiliations
Review

Reducing non-melanoma skin cancer risk in renal transplant recipients

Zaw Thet et al. Nephrology (Carlton). 2021 Nov.

Abstract

With an increasing number of renal transplant recipients (RTRs) and improving patient survival, a higher incidence of non-melanoma skin cancer (NMSC) has been observed. NMSC in RTRs are often more numerous and biologically more aggressive than the general population, thus contributing towards an increase in morbidity and to a lesser degree, mortality. The resultant cumulative health and financial burden is a recognized concern. Proposed strategies in mitigating risks of developing NMSC and early therapeutic options thereof include tailored modification of immunosuppressants in conjunction with sun protection in all transplant patients. This review highlights the clinical and financial burden of transplant-associated skin cancers, carcinogenic mechanisms in association with immunosuppression, importance of skin cancer awareness campaign and integrated transplant skin clinic, and the potential role of chemoprotective agents. A scheme is proposed for primary and secondary prevention of NMSC based on the available evidence.

Keywords: non-melanoma skin carcinoma; renal transplant; skin cancer; solid organ transplant.

PubMed Disclaimer

References

REFERENCES

    1. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166:1069-1080.
    1. Wheless L, Jacks S, Potter KA, Leach BC, Cook J. Skin cancer in organ transplant recipients: more than the immune system. J Am Acad Dermatol. 2014;71:359-365.
    1. Mittal A, Colegio OR. Skin cancers in organ transplant recipients. Am J Transplant. 2017;17:2509-2530.
    1. Park CK, Fung K, Austin PC, et al. Incidence and risk factors of keratinocyte carcinoma after first solid organ transplant in Ontario. Canada JAMA Dermatology. 2019;155:1041-1048.
    1. Garrett GL, Blanc PD, Boscardin J, et al. Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatol. 2017;153:296-303.

Substances

LinkOut - more resources